Abacavir 5'-glucuronide

BGC Id:	312914681486
CAS No:	384329-76-4
Synonyms:	abacavir 5'-b-d-glucuronide ; [(1s,4r)-4-[2-amino-6-(cyclopropylamino)-9h-purin-9-yl]-2-cyclopenten-1-yl]methyl-d-glucopyranosiduronic acid ; abacavir 5'-glucuronide ; abacavir 5'--d-glucuronide
Molecular Formula:	C20H26N6O7
Molecular Weight:	462.46
EINECS:

Verified providers in 2026

The following notable provider has been checked and can be recommended.

Leap Chem Co., Ltd

Company type: Bulk and laboratory supplier

Phone: +852-30606658
Country: P.R.China

LEAPChem, a specialized fine chemicals supplier for research, development and production. LEAPChem provides nearly 50,000 rare and innovative chemical products to support the evolving needs of our customers in research & bulk manufacturing activities. As a highly customer-oriented enterprise, we are committed to providing high-quality customer se ...

INQUIRY | ORDER

What other providers are available for CAS 384329-76-4?

The last intensive check and update was carried out on 2026/02/14.

Identify

Synonyms:

abacavir 5'-b-d-glucuronide ; [(1s,4r)-4-[2-amino-6-(cyclopropylamino)-9h-purin-9-yl]-2-cyclopenten-1-yl]methyl-d-glucopyranosiduronic acid ; abacavir 5'-glucuronide ; abacavir 5'--d-glucuronide

CAS:

384329-76-4

EINECS:

Molecular Formula:

C20H26N6O7

MDL:

Properties

Molecular Weight:

462.46 g·mol−1

Melting point:

>211 °C (dec.)

Safety Information

Hazard Classes:

Storage temperature:

-20 °C Freezer, Under Inert Atmosphere

What other providers are available for CAS 384329-76-4?

In addition to the providers presented here for Abacavir 5'-glucuronide with the CAS number 384329-76-4, there are other 7 providers with slightly different product names available for this CAS number.

Abacavir 5'-beta-D-glucuronide

Dayang Chem (Hangzhou) Co.,Ltd. | BIOZOL Diagnostica Vertrieb GmbH +2 additional providers that we know from the past

(3S,4S,5S,6R)-6-{[(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl]methoxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

+1 additional providers that we know from the past